Images List Premium Download Classic

Bowel

Bowel-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Methods for treating inflammatory bowel disease using prostate specific membrane antigen (psma) inhibitors
The Johns Hopkins University
August 10, 2017 - N°20170224709

Methods and compounds are disclosed for treating inflammatory bowel disease (ibd) by using prostate specific membrane antigen (psma) inhibitors.
Uses of salt-inducible kinase (sik) inhibitors
The General Hospital Corporation D/b/a Massachusetts General Hospital
August 10, 2017 - N°20170224700

The present disclosure provides methods of treating and/or preventing inflammatory bowel disease (ibd) and graft-versus-host disease (gvhd) using salt-inducible kinase (sik) inhibitors, such as macrocyclic sik inhibitors of formula (i), imidazolyl sik inhibitors of formula (ii), and urea and carbamate sik inhibitors of formula (iii-a) (e. G., urea and carbamate sik inhibitors of formula (iii)).
Application of andrographolide in the preparation of a pharmaceutical for treatment of inflammatory bowel disease, ...
Tasly Pharmaceutical Group Co., Ltd.
August 10, 2017 - N°20170224623

The present invention relates to an andrographolide enteric targeting micropellet and method for preparation thereof; furthermore, the present invention also relates to uses of andrographolide and andrographolide enteric targeting micropellets in the preparation of a pharmaceutical for treatment of inflammatory bowel disease.
Bowel Patent Pack
Download 226+ patent application PDFs
Bowel Patent Applications
Download 226+ Bowel-related PDFs
For professional research & prior art discovery
inventor
  • 226+ full patent PDF documents of Bowel-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamides and n-(4- hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamides and ...
Pimco 2664 Limited
August 03, 2017 - N°20170217881

The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain substituted n-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamide and n-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamide compounds (collectively referred to herein as hmc compounds) that are useful, for example, in the treatment of disorders (e. G., diseases) including, inflammation and/or joint destruction ...
Treatment of irritable bowel syndrome
Gruenenthal Gmbh
August 03, 2017 - N°20170216226

A method of treating irritable bowel syndrome in a patient in need thereof by administering to said patient a pharmaceutically effective amount of tapentadol.
Compositions, methods and kits for treating complement related disorders
Tufts University
July 27, 2017 - N°20170209535

Compositions, methods and kits are provided for treating complement related disorders in a subject with protein in combination having protein fusions of at least two of a cd46 protein, a cd55 protein and a cd59 protein or with a recombinant chimeric protein having at least two of a cd46 protein, a cd55 protein and a cd59 protein or with nucleic ...
Bowel Patent Pack
Download 226+ patent application PDFs
Bowel Patent Applications
Download 226+ Bowel-related PDFs
For professional research & prior art discovery
inventor
  • 226+ full patent PDF documents of Bowel-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Uses of 4'-desferrithiocin analogs
University Of Florida Research Foundation, Inc.
July 27, 2017 - N°20170209420

Macular degeneration, closed head injury, stroke, irritable bowel disease, and reperfusion injury are all associated with biological injury due to reactive oxygen species, probably due to focal iron overload in many instances. The present invention provides methods and pharmaceutical compositions for treating these diseases and conditions using desferrithiocin analogs of formula (i). In certain embodiments, the analogs include a polyether ...
Bowel care collection bag
University Of Florida Research Foundation, Inc.
July 27, 2017 - N°20170209128

Disclosed is a human waste collection device capable of collecting the human waste products into a collection bag for bedridden and incontinent patients, comprising the first female component, comprising a rectangular shaped base, with triangular sides, front and rear sides and hexagonal top, to adhere with the hexagonal shaped second male component, which thereby adhere together to a single united ...
Markers for inflammatory bowel disease
University Of Ottawa
July 20, 2017 - N°20170205429

There is provided protein biomarkers and methods for their use in diagnosing and treating inflammatory bowel disease (ibd), ulcerative colitis (uc) and crohn's disease (cd) as well as methods for assessing the severity of the diseases.
Pharmaceutical compositions comprising agonists of orexin-1 receptor ox1r for the treatment of inflammatory bowel ...
Assistance Publique-hopitaux De Paris
July 20, 2017 - N°20170202925

The present invention relates to methods and pharmaceutical compositions for the treatment of inflammatory bowel diseases. The presents methods relates to a method of treating an inflammatory bowel disease in a subject in need thereof comprising administering the subject with a therapeutically effective amount of at least one ox1r agonist.
Novel enteric combination therapy
Assistance Publique-hopitaux De Paris
July 20, 2017 - N°20170202905

There is disclosed herein a composition for treating gastrointestinal or neurological disorders, constipation, functional constipation, irritable bowel syndrome, diverticulitis, travelers diarrhea, chronic idiopathic nausea, ibd-associated constipation and diarrhea, pseudo-obstruction, diabetic gastroparesis, cyclic vomiting, reflux oesophagitis, autism enteropathy, flatulence, halitosis, chronic fatigue, bloating, proctalgia fugax, parkinsons disease, ms, alzheimers disease, motor neurone disease or autism, the composition comprising: (i) at least ...
Bowel movement prediction device and bowel movement prediction method
Triple W Japan K.k.
July 20, 2017 - N°20170202503

The bowel movement prediction device (100) includes an ultrasonic sensor (1) that detects a width of a rectum and a determiner (52) that determines a bowel movement timing based on an output of the ultrasonic sensor (1).
Core 22 human training and weight loss system
Triple W Japan K.k.
July 13, 2017 - N°20170200392

The system of the preferred embodiments is a method for human training coordinated by a computer interface, where a human user interacts with at least one computing interface; where the at least one computing is provided by a computing device having at least one processor, computer readable storage medium, and a network connection to at least one additional computing device; ...
Bowel Patent Pack
Download 226+ patent application PDFs
Bowel Patent Applications
Download 226+ Bowel-related PDFs
For professional research & prior art discovery
inventor
  • 226+ full patent PDF documents of Bowel-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Compositions comprising granulocyte-macrophage colony-stimulating factor for the treatment of inflammatory bowel disease
Reponex Pharmaceuticals Aps
July 13, 2017 - N°20170196937

The present invention provides compositions comprising granulocyte-macrophage colony-stimulating factor and fosfomycin for the treatment, prevention or alleviation of an inflammatory bowel disease such as crohn's disease, ulcerative colitis or necrotizing enterocolitis of newborn and premature infants by administration of the compositions into the intestinal lumen.
Mirna 320a as biomarker for inflammatory bowel disease
Westfaelische Wilhelms-universitaet Muenster
July 06, 2017 - N°20170191130

The present invention relates to an in vitro method for diagnosing an acute or relapsing phase of inflammatory bowel disease as well as a method for treating the acute or relapsing phase of inflammatory bowel disease. In addition, the present invention relates to a medicament for use in the treatment of inflammatory bowel disease. Further comprised by the present invention ...
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (trem-1)
Novo Nordisk A/s
July 06, 2017 - N°20170190775

The invention relates to antibodies that are capable of specifically binding trem-1 and preventing the activation of trem-1, a protein expressed on monocytes, macrophages and neutrophils. Such antibodies find utility in the treatment of individuals with an inflammatory disease, such as rheumatoid arthritis and inflammatory bowel disease.
2-aryl-4-hydroxy-1,3-thiazole derivatives useful as trpm8-inhibitors in treatment of neuralgia, pain, copd and ...
Novo Nordisk A/s
July 06, 2017 - N°20170190678

Said compounds are useful in the treatment of diseases associated with activity of trpm8 such as pain, inflammation, ischaemia, neurodegeneration, stroke, psychiatric disorders, itch, irritable bowel diseases, cold induced and/or exacerbated respiratory disorders and urological disorders.
Pd-l1 fusion protein and use thereof
Postech Academy-industry Foundation
July 06, 2017 - N°20170189476

The present invention relates to a fusion protein composed of the extracellular domain of pd-l1 and a modified immunoglobulin fc region. The extracellular domain of pd-l1 and a fragment thereof have excellent immunomodulatory activity, and can be used as an immunomodulatory agent if a modified immunoglobulin fc region is coupled thereto. Accordingly, the pd-l1 fusion protein according to the present ...
Tetrahydroisoquinolin-1-one derivative or salt thereof
Seldar Pharma Inc.
July 06, 2017 - N°20170189390

To provide a pharmaceutical, in particular a compound which can be used as a therapeutic agent for irritable bowel syndrome (ibs). It was found that a tetrahydroisoquinolin-1-one derivative having an amide group at the 4-position or a pharmaceutically acceptable salt thereof has an excellent bombesin 2 (bb2) receptor antagonistic action. It is also found that the tetrahydroisoquinolin-1-one derivative is ...
Method, composition and package for bowel cleansing
Seldar Pharma Inc.
July 06, 2017 - N°20170189360

The present invention provides a highly palatable colon cleansing formulation that utilizes a low chloride electrolyte-replenishing base solution. When formulated with polyethylene glycol and a selected sugar alcohol, the formulation offers the advantages of superior palatability without undesirable concomitant side effects or a decrease in cleansing efficacy.
Method of applying staples in lower anterior bowel resection
Ethicon Endo-surgery, Llc
July 06, 2017 - N°20170189022

A method for manipulating tissue of a patient includes a surgical instrument having a handle assembly, a shaft assembly, and an end effector. The method includes positioning a tissue within a gap between a cartridge and an anvil and against a guide pin to laterally position the tissue relative to the cartridge and the anvil. The method also includes moving ...
Loading